Tech Company Financing Transactions
NanoCor Therapeutics Funding Round
NanoCor Therapeutics, based in Chapel Hill, scored $3.8 million from Medtronic.
Transaction Overview
Company Name
Announced On
9/10/2007
Transaction Type
Venture Equity
Amount
$3,750,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
870 Martin Luther King Jr. Blvd.
Chapel Hill, NC 27514
USA
Chapel Hill, NC 27514
USA
Phone
Website
Email Address
Not Recorded
Overview
NanoCor intends to use its proprietary Biological Nanoparticle (BNP) technology platform and a proprietary, patent-protected gene to provide CHF patients worldwide with an effective, economic, and safe alternative.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sheila Mikhail
Chief Financial Officer
Rhonda Stanley
Chief Scientific Officer
Roger Hajjar
Founder
Evangelia Kranias
Founder
Jude Samulski
Browse more venture capital transactions:
Prev: 9/10/2007: ACTIVE Network venture capital transaction
Next: 9/10/2007: World Vital Records venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs